Generate a tailored SOP for Dr. Zaklina Kovacevic. Improve your application with a focused, well-structured draft.
Zaklina Kovacevic completed her PhD at the University of Sydney in 2011. Her research interests lie in the development of new classes of metal-binding thiosemicarbazones as anti-cancer agents and elucidating the molecular mechanisms underlying various cancers, particularly pancreatic, prostate, and breast cancers. Dr. Kovacevic has significantly contributed to understanding the function of the iron-regulated metastasis suppressor N-myc down-stream regulated gene 1 (NDRG1) and its role in cancer progression and chemotherapy resistance. In 2020, Dr. Kovacevic established her independent research group at the University of Sydney and relocated to UNSW in 2023, heading the Tumour Microenvironment group at the School of Biomedical Sciences. Her current research focuses on the interactions between cancer cells and the tumour microenvironment, with a particular interest in pancreatic cancer. Dr. Kovacevic has published 81 research outputs, with over 5500 citations, and has attracted more than $8.5 million in research grants, serving as the lead investigator for $3 million of this funding. Throughout her career, she has co-supervised and mentored 30 postgraduate students and is actively involved in peer review and grant assessment.
University of New South Wales • Sydney, Australia
Integrally involved in teaching undergraduate Medicine Physiology units.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.